ERIS Lifesciences Achieves New Milestone with 52-Week High Stock Price
ERIS Lifesciences, a midcap pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on August 19, 2024. According to MarketsMojo, the current recommendation for the company is 'Hold', based on its strong performance and market trends. ERIS Lifesciences has consistently outperformed the sector and its moving averages, showcasing its potential for growth.
ERIS Lifesciences, a midcap pharmaceutical company, has recently reached a new milestone as its stock price touched a 52-week high on August 19, 2024. This comes as a positive sign for the company, which has been steadily growing in the industry.
According to MarketsMOJO, a leading stock market analysis and research platform, the current recommendation for ERIS Lifesciences is 'Hold'. This is based on the company's recent performance and market trends.
The stock price of ERIS Lifesciences has been on an upward trend, hitting a new all-time high of Rs.1229.5 on the day. However, it underperformed the sector by -0.75% on the same day.
In terms of moving averages, ERIS Lifesciences is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong and consistent performance by the company.
In comparison to the Sensex, ERIS Lifesciences has shown a remarkable 1-year performance of 44.91%, while the Sensex has only grown by 23.96%. This showcases the company's strong growth potential and its ability to outperform the market.
ERIS Lifesciences is a midcap pharmaceutical company that has been making a mark in the industry with its consistent growth and performance. With its stock price reaching a new high, the company is poised for further success in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
